Cannara Biotech Inc. LOVFF
Rating
Rating Factors
Company Overview
Cannara Biotech Inc. is a Canada-based licensed cannabis producer focused on the cultivation, processing, and sale of premium and craft cannabis products. The company operates within the Canadian cannabis industry, primarily serving the adult-use recreational market, with a strategic emphasis on quality flower, concentrates, and derivative products. Its core revenue is generated through branded cannabis sales to provincial distributors, with a particularly strong market presence in Québec.
The company differentiates itself through in-house genetics, controlled indoor cultivation, and a brand portfolio positioned toward experienced consumers. Cannara Biotech Inc. was founded in 2017 and became publicly listed on the Toronto Stock Exchange in 2021. Since inception, the company has evolved from a development-stage cultivator into a scaled commercial producer with multiple cultivation and processing facilities, expanding its product breadth while maintaining a focus on operational efficiency and brand-driven growth.
Income Statement
Balance Sheet
Cash Flow
Filings
Price History
- Low
- $1.11
- Current
- $1.65
- High
- $1.56
Valuation
Dividends and Shares
Corporate Info
Suite 200
Saint-Laurent, QC H4N 3M9